The depyrogenated sterile empty vials market is poised to reach valuation of US$ 7,498.2 Mn by 2026, growing at a CAGR of 4.8% during forecast period 2019 to 2026.
LOS ANGELES, March 12, 2020 (GLOBE NEWSWIRE) -- Acumen Research and Consulting, a global provider of market research studies, in a recently published report titled “Depyrogenated Sterile Empty Vials Market (By Capacity: 2 ml, 5 ml, 10 ml, 20 ml, More than 20 ml; By Material: Glass, Plastic; By End-Use: Compounding Labs, Clinical Labs, Pharmaceutical Manufacturers, Others) – Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026”.
Get Free Report Sample Pages for Better Understanding@ https://www.acumenresearchandconsulting.com/request-sample/1772
In terms of end-use, compounding labs held the major share in 2018 due to the increasing demand for personalized medicines. The presence of stringent regulatory guidelines in major countries like the US for manufacturing and packaging of parenteral products, which needs the sterilization process to ensure the absence of endotoxin, RNase & DNase and other toxic substances. These kinds of regulation by regulatory bodies are supporting the market growth. Additionally, the presence of substantial compounding pharmacists in developed economies is further bolstering the market value. For instance, according to the International Academy of Compounding Pharmacists, approximately 7,500 compounding pharmacies in the U.S. itself are specialized in advanced compounding services, among them 3,000 pharmacies are involved in the compounding of sterile products.
On the basis of material, the glass segment accounted for the dominating share in 2018 owing to the benefits associated with the glass packaging. The depyrogenated sterile empty glass vials offer improved chemical durability and damage resistance which enable biopharmaceutical and pharmaceutical manufacturers to effectively store and deliver critical drug formulations is the primary factor supporting the segment market value. In addition to this, the increasing adoption of glass vials in plant cell culture, chemical and biological reactions, photobiological studies and in sample collection and storage is further accelerating the market growth.
View Detail Information with Complete TOC@ https://www.acumenresearchandconsulting.com/depyrogenated-sterile-empty-vials-market
In 2018, North America held the major share of the global depyrogenated sterile empty vials market. The increasing investment by pharma and biotech companies in R&D activities for the development of innovative packaging is primarily driving the regional market growth. The region is majorly dependent on the US market, which is the prominent segment of the North America region in terms of both volume and value of depyrogenated sterile empty vials market. For instance, the U.S. President promoted a collaboration in 2017, which was intended to enhance the storage and delivery of pharmaceutical formulations. The initiative was conducted and driven by specialty glass marker Corning, Inc. and two pharmaceutical companies namely, Pfizer, Inc. and Merck, Co. The increasing focus towards the technological advancements in healthcare sector packaging by governmental bodies and major players due to increasing focus towards the sterility is additionally propelling the market value. For instance, the EZ-fill Platform developed by Stevanato Group is particularly designed for use in the manufacturing of sterile depyrogenated vials. The platform offers cost reductions, production process improvement, more flexibility, quality improvement and mitigates risks of breakage, as in turn reduces rejection rate.
Some of the leading competitors are Corning Incorporated, Thermo Fisher Scientific, APG Pharma, DWK Life Sciences, VWR International, Nipro PharmaPackaging, Gerresheimer, Merck KGaA, Radpharm Scientific, Stevanato Group, and SCHOTT. Depyrogenated sterile empty vials companies have announced mergers and acquisitions to expand their position in the depyrogenated sterile empty vials industry. Major players are also moving into new regions with advanced technologies and product offerings. The major companies also offer the product with the Certificates of Analysis (COA) and Certificates of Conformance (COC) by lot number.
Related Reports
- Compounding Pharmacies Market – https://finance.yahoo.com/news/compounding-pharmacies-market-hit-around-140010039.html
- Prosthetics and Orthotics Market – https://finance.yahoo.com/news/prosthetics-orthotics-market-worth-us-140010572.html
- Lasik Eye Surgery Devices Market - https://finance.yahoo.com/news/lasik-eye-surgery-devices-market-132817986.html
Some of the key observations regarding depyrogenated sterile empty vials industry include:
- Schott AG has collaborated with the SINDAC, a French engineering firm in 2019 in order to expand its portfolio in advance pharmaceutical packaging.
- In 2018, SGD Pharma has introduced Clareo range of molded glass vials for injectable solutions and that too with more flat and uniform bottoms. The benefit of flat and uniform bottoms is easy thermal transfer during freeze-drying processes. The new product development is particularly to expand the product portfolio of the company.
- The Environmental Protection Agency (EPA) has updated Management Standards for Hazardous Waste Pharmaceuticals and Amendment to the P075 Listing for Nicotine, 5. As result, companies are required to determine the applied definitions according to their offerings.
- Cherwell Laboratories has introduced a new Redipor Broth Kit in 2019, which is designed to help with microbiological QA/QC and monitoring applications. The kit comprises of three empty 30 ml sterile injection vials, a 50 ml Tryptic Soy Broth (TSB) injection vial, a 100 ml TSB broth bag and one 10 ml TSB ampoule.
Request for Customization@ https://www.acumenresearchandconsulting.com/request-customization/1772
The report is readily available and can be dispatched immediately after payment confirmation.
Buy this premium research report@ https://www.acumenresearchandconsulting.com/buy-now/0/1772
If you would like to place an order or have any questions, please feel free to contact at sales@acumenresearchandconsulting.com | +1 407 915 4157 OR +1 408 900 9135
For Latest Update Follow Us:
https://www.facebook.com/acumenresearchandconsulting
https://www.linkedin.com/company/acumen-research-and-consulting/